Philip Morris International (NYSE:PM – Get Free Report) had its price objective increased by research analysts at Argus from $210.00 to $220.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Argus‘s price objective suggests a potential upside of 9.32% from […]

Honeywell International (NASDAQ:HON – Free Report) had its price target lifted by JPMorgan Chase & Co. from $240.00 to $241.00 in a research report released on Friday,Benzinga reports. The firm currently has an overweight rating on the conglomerate’s stock. Several other analysts have also commented on the company. Jefferies Financial Group assumed coverage on Honeywell […]

Marriott International (NASDAQ:MAR – Free Report) had its price target boosted by Morgan Stanley from $384.00 to $403.00 in a research report report published on Thursday,Benzinga reports. They currently have an overweight rating on the stock. A number of other brokerages have also recently commented on MAR. The Goldman Sachs Group dropped their price objective […]

BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its price objective increased by JPMorgan Chase & Co. from $86.00 to $87.00 in a research note published on Tuesday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the biotechnology company’s stock. Several other equities analysts also recently commented on the company. UBS Group started […]

Oric Pharmaceuticals (NASDAQ:ORIC – Free Report) had its target price boosted by JPMorgan Chase & Co. from $23.00 to $26.00 in a research report released on Wednesday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. ORIC has been the subject of several other research reports. Weiss Ratings restated a […]